Related Experiment Video
Updated: Jul 29, 2025

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction
Paolo Severino1, Andrea D'Amato1, Silvia Prosperi1
1Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Viale del Policlinico, 155, 00161 Rome, Italy.
Insights
Myocardial infarction with non-obstructive coronary artery disease (MINOCA) is a common cause of death. Coronary microvascular dysfunction (CMD) is a key factor, and understanding its genetic basis is crucial for future treatments.
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Background:
- Ischemic heart disease (IHD) is a leading global cause of mortality.
- Myocardial infarction with non-obstructive coronary artery disease (MINOCA) is an increasingly recognized clinical entity.
- MINOCA encompasses diverse mechanisms, including atherosclerotic and non-atherosclerotic causes.
Purpose of the Study:
- To review the pathophysiology of MINOCA.
- To focus on coronary microvascular dysfunction (CMD) as a key mechanism in MINOCA.
- To explore the current understanding of genetic predisposition to CMD.
Main Methods:
- Literature review of MINOCA pathophysiology.
- Analysis of CMD mechanisms in MINOCA.
- Examination of genetic factors implicated in CMD.
Main Results:
- Coronary microvascular dysfunction (CMD) significantly contributes to MINOCA pathophysiology and prognosis.
- Genetic susceptibility is hypothesized to play a role in the development of CMD.
- Current knowledge on the genetic mechanisms underlying CMD is limited.
Conclusions:
- Further research is essential to elucidate the genetic basis of CMD.
- Understanding genetic variants in microcirculation dysfunction can lead to early risk identification.
- Tailored pharmacological strategies for MINOCA patients can be developed through genetic insights.
Abstract:
Among the most common causes of death worldwide, ischemic heart disease (IHD) is recognized to rank first. Even if atherosclerotic disease of the epicardial arteries is known as the leading cause of IHD, the presence of myocardial infarction with non-obstructive coronary artery disease (MINOCA) is increasingly recognized. Notwithstanding the increasing interest, MINOCA remains a puzzling clinical entity that can be classified by distinguishing different underlying mechanisms, which can be divided into atherosclerotic and non-atherosclerotic. In particular, coronary microvascular dysfunction (CMD), classifiable in non-atherosclerotic mechanisms, is a leading factor for the pathophysiology and prognosis of patients with MINOCA. Genetic susceptibility may have a role in primum movens in CMD. However, few results have been obtained for understanding the genetic mechanisms underlying CMD. Future studies are essential in order to find a deeper understanding of the role of multiple genetic variants in the genesis of microcirculation dysfunction. Progress in research would allow early identification of high-risk patients and the development of pharmacological, patient-tailored strategies. The aim of this review is to revise the pathophysiology and underlying mechanisms of MINOCA, focusing on CMD and actual knowledge about genetic predisposition to it.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis I: Introduction
Coronary Artery Disease III: Clinical Manifestations